<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body> <br />                          Generation set conditional <br />                         analog-sensitive alleles essential <br />                         protein kinases fission yeast <br />                            Schizosaccharomyces pombe <br />  <br />                              Key words: kinase, analog-sensitive, conditional allele, fission yeast, phosphorylation <br />  <br />  <br />           genome fission yeast Schizosaccharomyces pombe encodes 17 protein kinases essential viability. <br />           Studies essential kinases require use mutant strains carrying conditional alleles. inactivate           kinases conditionally, applied recently developed <span id='am-1' about='obo:IMR_0000947' typeof='owl:Thing obo:IMR_0000001'><span id='am-2' property="rdfs:label" content="chemical" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:id" content="IMR:0000947" datatype="xsd:string"></span>chemical</span> genetic strategy. mutation single residue           <span id='am-6' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-7' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-10' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-15' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-16' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span>ATP</span>-binding pocket confers sensitivity small-molecule inhibitors, allowing specific inactivation modified <br />           kinase. Using approach, constructed conditional analog-sensitive alleles 13 essential protein kinases           fission yeast S. pombe. <br />  <br />  <br />  <br />                                Introduction                                            viability.7,8 created heterozygous diploid deletion strains                                                                                        18 kinases analyzed haploid products established reversible protein phosphorylation                      sporulation. confirmed 17 kinase genes essential major mechanisms cellular processes                            viability.  sporulation heterozygous diploid <br /> regulated.1,2 analysis protein kinases phosphatases                     deletion strain, followed dissection asci rich instrumental various fields cell biology. fission                       medium, showed kinases, ppk28, essential <br /> yeast Schizosaccharomyces pombe excellent model organism                         viability (data shown). observation consistent studying eukaryotic biology, amenable genetic,                    previous reports showing ppk28 dispensable normal <br /> biochemical cytological techniques genome-wide                          cell growth.9 17 essential kinases, analog-sen- <br /> approaches.3-5 S. pombe genome encodes 107 predicted pro-                          sitive allele (ark1&#194;&#160;as3)10 available started proj- <br /> tein kinases, 17 known essential cell                        ect.  decided create conditional analog-sensitive <br /> growth. <span id='am-5' about='oboInOwl:date' typeof='owl:Thing'>date</span>, studies essential protein kinases fission                   alleles 16 remaining protein kinases essential viability <br /> yeast relied use mutant strains carrying                         (Table 1). <br /> conditional temperature-sensitive alleles.  alleles                          create conditional analog-sensitive alleles, mutated leaky require analysis non-physiological                           gate-keeper residue kinase ATP-binding site conditions, inactivation requires long period time.                     <span id='am-36' about='obo:IMR_0100118' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-37' property="rdfs:label" content="Gly" datatype="xsd:string"></span><span id='am-38' property="rdfs:label" content="Glycine" datatype="xsd:string"></span><span id='am-39' property="rdfs:label" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasExactSynonym" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:hasExactSynonym" content="Glycine" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasExactSynonym" content="Gly" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasAlternativeId" content="IMR:0200057" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasDbXref" content="KEGG:C00037" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:id" content="IMR:0100118" datatype="xsd:string"></span><span id='am-47' property="rdfs:label" content="glycine" datatype="xsd:string"></span>glycine</span> (as1) alanine (as2). mutations expressed recently developed chemical genetic strategy sensitizing                         S. pombe strain lacking wild-type allele corre- <br /> protein kinases small-molecule inhibitors provides elegant                       sponding kinase according protocol Gregan et al.11 <br /> tool constructing conditional analog-sensitive kinase alleles                      16 kinases mutated gate-keeper residue, 13 <br /> (Fig.&#194;&#160;1).6 current study, used strategy create                       remained functional indicated growth haploid cells car- <br /> analog-sensitive alleles S. pombe protein kinases essen-                   rying corresponding gate-keeper mutation YES medium <br /> tial cell growth.                                                                  (Table&#194;&#160;1 Figs. 3 S1). Tetrad analysis heterozygous <br />                                                                                        diploid strains showed remaining mutants (cdc7- <br />                                   Results                                               hsk1 sid1  functional (Table 1).                                                                                        observed mutants (cdc2-as1 pat1  sensitive recent systematic deletion analysis genes fission                          elevated temperature (32&#194;&#176;C), grew normally low <br /> yeast S. pombe revealed 18 protein kinases essential                      temperature (25&#194;&#176;C). temperature sensitivity cdc2-as1  <br />  *Correspondence  Juraj Gregan; Email: juraj.gregan@univie.ac  Submitted: 07/26/11; Accepted: 08/17/11 <br />  http://dx.doi.org/10.4161/cc.10.20.17791 <br />  <br />  <br /> www.landesbioscience.com	                                                     Cell Cycle	                                                                            3527 <br />   Figure 1. Chemical genetic strategy sensitizing protein kinases small-molecule inhibitors. Mutation gate-keeper residue protein ki- <br />  nase (kinase  creates new pocket ATP analog (inhibitor) bind. Binding inhibitor kinase leads inactivation kinase <br />   .  kinase mutation typically does interfere kinase function absence inhibitor (B). inhibitor bind <br />  wild-type kinases, allowing specific inactivation mutant kinase (C).6 <br />  <br />  <br />  <br />                                                                                                   addition mutants created                                                                                                   study, included previously constructed <br />                                                                                                   ark1-as3 mutant analysis.10 Spot test                                                                                                   YES plates showed mutants                                                                                                   highly sensitive tested <br />                                                                                                   inhibitors (&#226;&#8240;&#164;10 mM ATP analog),                                                                                                   mutants exhibited sensitivity higher <br />                                                                                                   concentrations inhibitors (Table&#194;&#160;2                                                                                                   Fig.&#194;&#160;3). characterize mutant <br />                                                                                                   phenotypes, added inhibitor cultures <br />                                                                                                   exponentially growing liquid YES medium <br />                                                                                                   analyzed effect inhibitors cell <br />                                                                                                   growth counting cell number. hours <br />                                                                                                   adding inhibitor, harvested cells <br />                                                                                                   analyzed morphology cells                                                                                                   microscopy cellular DNA content                                                                                                   flow cytometry (Fig.&#194;&#160;S1). analyses  <br />                                                                                                   firmed 13 kinase mutants sen- <br />                                                                                                   sitive tested inhibitors, <br />                                                                                                   growth mutant cells                                                                                                   inhibited (7 mutants) completely blocked <br />  Figure 2. Chemical structures inhibitors used study. <br />                                                                                                   (6&#194;&#160;mutants) presence inhibitor <br />                                                                                                   (Fig. S1).  conclude analog- <br />                                                                                                   sensitive alleles constructed 13 described previously references 12 13.                    16 essential kinases.  chemical genetic strat- 16 essential kinases, constructed 13 functional alleles              egy conditional inactivation protein kinases creating gate-keeper residue replaced <span id='am-48' about='obo:IMR_0100118' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-49' property="rdfs:label" content="Glycine" datatype="xsd:string"></span><span id='am-50' property="oboInOwl:hasExactSynonym" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-51' property="oboInOwl:id" content="IMR:0100118" datatype="xsd:string"></span><span id='am-52' property="oboInOwl:hasExactSynonym" content="Gly" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasAlternativeId" content="IMR:0200057" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-55' property="oboInOwl:hasExactSynonym" content="Glycine" datatype="xsd:string"></span><span id='am-56' property="oboInOwl:hasDbXref" content="KEGG:C00037" datatype="xsd:string"></span><span id='am-57' property="rdfs:label" content="glycine" datatype="xsd:string"></span><span id='am-58' property="rdfs:label" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-59' property="rdfs:label" content="Gly" datatype="xsd:string"></span>glycine</span>                  mutants sensitive ATP analogs viable option studying <br /> alanine.                                                                       S. pombe protein kinases essential cell growth    test sensitivity 13 kinase mutants inhibitors,             encourage wider use strategy yeast synthesized different inhibitors (ATP analogs) (Fig.&#194;&#160;2).              organisms. <br />  <br />  <br />  <br /> 3528	                                                                  Cell Cycle	                                                       Volume 10 Issue 20 <br />                              Discussion                                     Table&#194;&#160;1. Functionality analog-sensitive kinase mutants determined <br />                                                                            growth YES plates <br />  study, created conditional analog-sensitive alleles               Kinase <br />                                                                                              Gate keeper           Functionality 13 S. pombe protein kinases. mutants                                   residue                mutants <br /> described course work.12,14-17                                                   as1 (<span id='am-24' about='obo:IMR_0100118' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-25' property="oboInOwl:hasExactSynonym" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:id" content="IMR:0100118" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:hasExactSynonym" content="Glycine" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasExactSynonym" content="Gly" datatype="xsd:string"></span><span id='am-30' property="rdfs:label" content="glycine" datatype="xsd:string"></span><span id='am-31' property="rdfs:label" content="Gly" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasAlternativeId" content="IMR:0200057" datatype="xsd:string"></span><span id='am-33' property="rdfs:label" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasDbXref" content="KEGG:C00037" datatype="xsd:string"></span><span id='am-35' property="rdfs:label" content="Glycine" datatype="xsd:string"></span>Gly</span>)*         as2 (Ala)* <br /> seven mutants highly sensitive tested                Cdc2              F84                     yes&#226;&#8364;&#160;                    - <br /> inhibitors, mutants exhibited sensitivity higher                Cdc7              L85                                      centrations inhibitors. future, useful                                                                                 Cdk9              T120                    yes&#226;&#8364;&#160;                    - <br /> optimize mutants increase sensitivity inhibitors. <br />                                                                                 Cka1              F117                    yes&#226;&#8364;&#160;                addition, kinases did tolerate mutation gate-keeper residue potentially salvaged second-site               Crk1             L87                     yes                 suppressor mutations.18 growing number studies shown                  Hsk1              L173                                     small-molecule inhibitors selective target kinases ben-            Ksg1              L177                    yes   &#226;&#8364;&#160; <br />                                                                                                                                                   - <br /> eficial conditional inactivation.19,20  believe           Nak1              M88                     yes                 analog-sensitive alleles constructed study provide           Orb6             M170                     yes&#226;&#8364;&#160;                    - <br /> valuable tool studying protein kinases. ATP analogs                                                                                  Pat1             L95                     yes                 yes <br /> usually cell permeable, allowing rapid reversible inhibi- <br />                                                                                  Plo1             L117                    yes&#226;&#8364;&#160;                    - <br /> tion target protein kinase. important advantage rapid <br /> inactivation kinase cell little time com-             Ppk37            M537                     yes                 yes <br /> pensate missing kinase activity. addition, depending               Prp4             F238                                     yes inhibitor added, total partial inhibition               Shk1             M460                                      yes <br /> target kinase achieved. Finally, small-molecule inhibitor               Sid1             M84                                      genetic mutation perturb activity kinase                   Sid2            M285                     yes                 different ways result different phenotypes.  <br />                                                                            *gate-keeper residue mutated glycine (Gly) alanine (Ala), <br /> analog-sensitive alleles reveal new biological functions            respectively; &#226;&#8364;&#160;sensitive &#226;&#8240;&#164;10 &#206;&#188;M ATP analog. <br /> kinases.11,19,21 <br />     analog-sensitive alleles described provide new tool studying protein kinases, comple-            Sytox-Green staining (FACS analysis) followed previ- <br /> ment currently available conditional alleles. example,            ously described reference 24. <br /> analog-sensitive alleles combined temperature-                 Deletion genes encoding essential kinases. delete <br /> sensitive alleles create double mutants temper-           genes encoding essential kinases, used approach <br /> ature-sensitive protein inactivated shifting cells           based knockout constructs contain 150&#226;&#8364;&#8220;800 bp long <br /> non-permissive temperature, analog-sensitive kinase           regions homologous target genes cloned vector- independently inactivated adding inhibitor. Notably,           carrying dominant drug-resistance markers.23 oligonucle- tested ATP analogs inhibit subset kinase mutants         otides designed according database S. pombe <br /> (Table 2), raises possibility analog-          deletion     constructs     (mendel.<span id='am-60' about='obo:IMR_0200221' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-61' property="oboInOwl:id" content="IMR:0200221" datatype="xsd:string"></span><span id='am-62' property="rdfs:label" content="IMP" datatype="xsd:string"></span><span id='am-63' property="oboInOwl:hasDbXref" content="KEGG:C00130" datatype="xsd:string"></span><span id='am-64' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>imp</span>.ac Pombe_deletion). <br /> sensitive alleles combined double-mutant strains          Sequences flanking genes encoding essential kinases <br /> separately inactivated specific inhibitors.                          PCR-amplified S. pombe genomic DNA using     fission yeast Schizosaccharomyces pombe excellent           primers up upstream regions model organism studying various aspects biology,            downstream regions (Table S1). resulting likely analog-sensitive alleles described work        PCR products ligated  proximal ends useful tool future studies. notable          cloned pCloneNat1 vector (EF101285) carrying 3 16 kinases did tolerate mutation gate-       drug resistance markers E. coli (Ampicillin) S. pombe <br /> keeper residue. gate-keeper residue easily identified       (Nourseothricin), resulting pCloneNat1-&#206;&#8221;kinase plasmids. protein kinases (reviewed ref. 11 sequoia.ucsf.edu/        plasmids amplified E. coli, purified linearized <br /> ksd), expect strategy work          restriction enzymes (Table&#194;&#160;S2). linearized plasmids <br /> protein kinases.                                                          used delete respective kinases diploid strain <br />                                                                           (JG11315). Successful deletion confirmed colony PCR <br />                     Materials Methods                                 tetrad analysis. <br />                                                                              Construction analog sensitive   kinase mutants. Strains general methods. genotypes yeast strains           coding sequences kinase genes promoter used study listed Table 3. Schizosaccharomyces             terminator regions PCR-amplified S. pombe genomic <br /> pombe strains maintained grown using standard condi-             DNA using forward reverse primers, kinase promotor <br /> tions.22 transformation S. pombe performed using           kinase terminator, respectively (Table S2). PCR prod- <br /> lithium acetate method previously described reference&#194;&#160;23.           ucts cloned pCloneHyg1 vector (EF101286) carry- <br /> Procedures Hoechst staining (fluorescence microscopy)             ing drug resistance markers E. coli (Ampicillin) S.&#194;&#160;pombe <br />  <br />  <br /> www.landesbioscience.com	                                         Cell Cycle	                                                                         3529 <br />   Table&#194;&#160;2. Sensitivity analog-sensitive kinase mutants various ATP analogs <br />                 Sensitivity inhibitors [&#206;&#188;M] <br />                           1-NM-PP1                 2-NA-PP1       9-CH-ANPUR        9-TOL-ANPUR         2,3-DMP-PP1       Bn-PP1      3-MB-PP1         3-BrB-PP1 <br />   ark1-as3                    5.0                      5.0             n.s.               40.0               5.0            10.0          10.0            10.0 <br />   cdc2-as1                    0.5                      5.0             5.0                5.0                5.0             5.0          5.0              5.0 <br />   cdk9-as1                   10.0                     20.0             20.0               10.0               n.s.            n.s.         10.0            10.0 <br />   cka1-as1                   n.s.                      n.s.            5.0                30.0               n.s.            n.s.         n.s.            40.0 <br />   crk1-as1                   n.s.                      n.s.            n.s.               n.s.               n.s.            n.s.         n.s.            30.0 <br />   ksg1-as1                    5.0                     20.0             20.0               10.0               n.s.           20.0          5.0              5.0 <br />   nak1-as1                   n.s.                      n.s.            n.s.               n.s.               n.s.            n.s.         n.s.            40.0 <br />   orb6-as1                   10.0                     10.0             20.0               10.0               10.0           10.0          10.0             5.0 <br />   pat1-as2                   10.0                     20.0             n.s.               10.0               30.0           30.0          n.s.            30.0 <br />   plo1-as1                   30.0                      n.s.            n.s.               n.s.               n.s.            n.s.         40.0            10.0 <br />  ppk37-as1                   30.0                      n.s.            n.s.               n.s.               n.s.            n.s.         30.0            30.0 <br />   prp4-as2                   n.s.                      n.s.            n.s.               n.s.               n.s.            n.s.         n.s.            30.0 <br />   shk1-as2                   n.s.                      n.s.            n.s.               30.0               n.s.            n.s.         n.s.            20.0 <br />   sid2-as1                   n.s.                      n.s.            n.s.               n.s.               n.s.            n.s.         n.s.            40.0 <br />  n.s., sensitive. <br />  <br />  <br />  <br />  <br />  Figure 3. Sensitivity cells expressing analog-sensitive kinase alleles various inhibitors. Serial dilutions wild-type cells cells expressing indi- <br />  cated analog-sensitive kinase alleles spotted YES plates containing lacking indicated inhibitors grown 32&#194;&#176;C 3&#226;&#8364;&#8220;4 days,  exception temperature-sensitive mutants cdc2-as1 pat1-as2, grown 25&#194;&#176;C 4 days. Concentrations inhibitors  described Table 2. <br />  <br />  <br />  <br /> (Hygromycin&#194;&#160;B), resulting integrative pCloneHyg1-kinase                        unique restriction enzyme cuts promoter region <br /> plasmids. plasmids amplified E. coli, purified                    kinase gene (Table S2) transformed diploid <br /> sequenced exclude clones PCR-introduced mutations.                    strain heterozygous deletion respective kinase. create mutant strains carrying conditional analog-sensitive                    selected transformants sporulated 25&#194;&#176;C, haploids car- <br /> alleles, employed site directed mutagenesis (QuikChangeII,                     rying analog-sensitive kinase alleles selected based resis- <br /> Site Directed Mutagenesis Kit) mutated predicted gate-                    tance Nourseothricin Hygromycin. Correct integration keeper residues small <span id='am-17' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-18' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-20' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-23' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span>amino acid</span> residues (Table 1, sequoia.                   mutant kinase alelles confirmed colony PCR. pres- <br /> ucsf.edu/ksd).11 sequences primers used mutagen-                       ence mutant alleles selected haploid strains verified <br /> esis listed Table&#194;&#160;S3. resulting plasmids pCloneHyg1-                   sequencing PCR-amplified kinase alleles genomic <br /> kinase-as1 pCloneHyg1-kinase-as2 linearized                       DNA. <br />  <br />  <br /> 3530	                                                                     Cell Cycle	                                                            Volume 10 Issue 20 <br />   Table&#194;&#160;3. Yeast strains used study <br />            Strain                                                                                   Genotype <br />           JG15459                                                                                        h- <br />           JG15401                                                                 h+ ark1 L166A, S229A, Q28R, Q176R)-HphR <br />           JG11315                                                        h+/h- leu1&#226;&#8364;&#8220;32/leu1&#226;&#8364;&#8220;32 ura4-D18/ura4-D18 ade6-M210/ade6-M216 <br />           JG15442                                                    h leu1&#226;&#8364;&#8220;32 ura4-D18 ade6-M216 cdc2::ClonNatR cdc2 F84G)-HphR <br />                                                                          - <br />  <br />  <br />           JG15172                                                   h- leu1&#226;&#8364;&#8220;32 ura4-D18 ade6-M210 cdk9::ClonNatR cdk9 T120G)-HphR <br />           JG15446                                                   h- leu1&#226;&#8364;&#8220;32 ura4-D18 ade6-M216 cka1::ClonNatR cka1 F117G)-HphR <br />           JG15452                                                              h- leu1&#226;&#8364;&#8220;32 ura4-D18 ade6-M210 crk1 L87G)-HphR <br />           JG15433                                                   h leu1&#226;&#8364;&#8220;32 ura4-D18 ade6-M210 ksg1::ClonNatR ksg1 L177G)-HphR <br />                                                                          - <br />  <br />  <br />           JG15448                                                             h- leu1&#226;&#8364;&#8220;32 ura4-D18 ade6-M210 nak1 M88G)-HphR <br />           JG15439                                                   h leu1&#226;&#8364;&#8220;32 ura4-D18 ade6-M216 orb6::ClonNatR orb6 M170G)-HphR <br />                                                                      - <br />  <br />  <br />           JG15404                                                    h- leu1&#226;&#8364;&#8220;32 ura4-D18 ade6-M216 pat1::ClonNatR pat1 L95G)-HphR <br />           JG15403                                                    h- leu1&#226;&#8364;&#8220;32 ura4-D18 ade6-M210 pat1::ClonNatR pat1 L95A)-HphR <br />           JG15431                                                    h- leu1&#226;&#8364;&#8220;32 ura4-D18 ade6-M216 plo1::ClonNatR plo1 L117G)-HphR <br />           JG16103                                                  h- leu1&#226;&#8364;&#8220;32 ura4-D18 ade6-M216 ppk37::ClonNatR ppk37 M537G)-HphR <br />           JG16101                                                  h- leu1&#226;&#8364;&#8220;32 ura4-D18 ade6-M210 ppk37::ClonNatR ppk37 M537A)-HphR <br />           JG15934                                                   h- leu1&#226;&#8364;&#8220;32 ura4-D18 ade6-M210 prp4::ClonNatR prp4 F238A)-HphR <br />           JG15927                                                   h- leu1&#226;&#8364;&#8220;32 ura4-D18 ade6-M210 shk1::ClonNatR shk1 M460A)-HphR <br />           JG15450                                                             h- leu1&#226;&#8364;&#8220;32 ura4-D18 ade6-M210 sid2 M285G)-HphR <br />  <br />  <br />    Analysis sensitivity kinase mutants ATP analogs.                                                               <br /> test strains mutated gate-keeper residue sensitive                        ATP analogs, dilution spot test used. Serial dilutions                  cells spotted YES plates supplemented various                                 <br /> ATP analogs DMSO, grown 32&#194;&#176;C 3&#226;&#8364;&#8220;4 d,                                 <br /> exception temperature-sensitive mutants, cdc2-as1                <br /> pat1-as2, grown 25&#194;&#176;C 4 d. determination                              growth rates cellular morphology FACS analysis                       <br /> performed cells growing liquid YES medium supple-                                     <br /> mented various ATP analogs.25 <br />                                                                                                 <br />                 Disclosure Potential Conflicts                            potential conflicts disclosed.                                           <br /> </body></html>